Updated:
Propel Bio Partners
We help entrepreneurial life science companies advance groundbreaking technologies and therapies that improve human health.Propel Bio Partners builds...
Propel Bio Partners
We help entrepreneurial life science companies advance groundbreaking technologies and therapies that improve human health.Propel Bio Partners builds ecosysystems to help founders achieve their vision.
General information
Firm type
Private Equity
Year founded
2022
Location
Region
North America
Country
United States
City
Los Angeles
Corporate office
11620 Wilshire Blvd., Suite 350, Los Angeles, CA 90025, United States
Additional offices
Seattle, WA, United States
Principals
Laurie Heilmann
Venture Partner
Joyce Jiang
Analyst
Safiya Alavi
Associate, Data Science and Research
Sam Berry
Analyst
Carol Criner
Advisor
Richard Sudek
Advisor
Suzanne Hendrix
Advisor
Ronald Lee Krall
Senior Advisor
Sector focus
Frequently asked questions
What is Propel Bio Partners?
Propel Bio Partners is a private equity headquartered in Los Angeles, United States.
When was Propel Bio Partners founded?
Propel Bio Partners was founded in 2022.
Where is Propel Bio Partners headquartered?
Propel Bio Partners is headquartered in Los Angeles, United States, in the North America region.
What does Altss track for Propel Bio Partners?
Altss maintains an OSINT-verified profile of Propel Bio Partners covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Propel Bio Partners's website?
Propel Bio Partners's public website is propelbio.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Propel Bio Partners?
Propel Bio Partners is classified by Altss as a Private Equity, operating from United States within the North America region.
How does Altss source intelligence on Propel Bio Partners?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Propel Bio Partners's Altss profile last updated?
Propel Bio Partners's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: